DE69609201T2 - 21-[2-oxo-tetrahydrofuran]-thio pregnan derivative, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon - Google Patents

21-[2-oxo-tetrahydrofuran]-thio pregnan derivative, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon

Info

Publication number
DE69609201T2
DE69609201T2 DE69609201T DE69609201T DE69609201T2 DE 69609201 T2 DE69609201 T2 DE 69609201T2 DE 69609201 T DE69609201 T DE 69609201T DE 69609201 T DE69609201 T DE 69609201T DE 69609201 T2 DE69609201 T2 DE 69609201T2
Authority
DE
Germany
Prior art keywords
pct
thio
oxo
tetrahydrofuran
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69609201T
Other languages
English (en)
Other versions
DE69609201D1 (de
Inventor
Keith Biggadike
Mary Farrell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9526630.0A external-priority patent/GB9526630D0/en
Priority claimed from GBGB9613036.4A external-priority patent/GB9613036D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE69609201D1 publication Critical patent/DE69609201D1/de
Publication of DE69609201T2 publication Critical patent/DE69609201T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
DE69609201T 1995-12-29 1996-12-19 21-[2-oxo-tetrahydrofuran]-thio pregnan derivative, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon Expired - Fee Related DE69609201T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9526630.0A GB9526630D0 (en) 1995-12-29 1995-12-29 Compounds
GBGB9613036.4A GB9613036D0 (en) 1996-06-21 1996-06-21 Compounds
PCT/GB1996/003153 WO1997024367A1 (en) 1995-12-29 1996-12-19 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
DE69609201D1 DE69609201D1 (de) 2000-08-10
DE69609201T2 true DE69609201T2 (de) 2001-03-01

Family

ID=26308399

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69609201T Expired - Fee Related DE69609201T2 (de) 1995-12-29 1996-12-19 21-[2-oxo-tetrahydrofuran]-thio pregnan derivative, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon

Country Status (12)

Country Link
US (1) US6013244A (de)
EP (1) EP0876393B1 (de)
JP (1) JP2947945B2 (de)
AT (1) ATE194357T1 (de)
AU (1) AU1200097A (de)
DE (1) DE69609201T2 (de)
DK (1) DK0876393T3 (de)
ES (1) ES2150151T3 (de)
GR (1) GR3034563T3 (de)
PT (1) PT876393E (de)
SI (1) SI0876393T1 (de)
WO (1) WO1997024367A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE260931T1 (de) * 1997-06-30 2004-03-15 Glaxo Group Ltd Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
AU2003263717A1 (en) * 2002-09-25 2004-04-19 Astrazeneca Ab A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
WO2008124145A1 (en) * 2007-04-05 2008-10-16 Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services Steroid compounds, compositions, and methods of treatment
CL2008003802A1 (es) * 2007-12-21 2010-02-19 Schering Corp Compuestos derivados de tioeteres c-21, agonistas del receptor de glucocorticoide; composicion farmaceutica; y uso para el tratamiento o profilaxis de una enfermedad o afeccion inmune, autoinmune o inflamatoria, tales como artritis reumatoide y esclerosis multiple.
AU2010260177A1 (en) 2009-06-16 2011-12-15 Merck Sharp & Dohme Corp. Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use

Also Published As

Publication number Publication date
PT876393E (pt) 2000-12-29
US6013244A (en) 2000-01-11
AU1200097A (en) 1997-07-28
JP2947945B2 (ja) 1999-09-13
EP0876393A1 (de) 1998-11-11
EP0876393B1 (de) 2000-07-05
WO1997024367A1 (en) 1997-07-10
ATE194357T1 (de) 2000-07-15
GR3034563T3 (en) 2001-01-31
DE69609201D1 (de) 2000-08-10
ES2150151T3 (es) 2000-11-16
DK0876393T3 (da) 2000-11-06
SI0876393T1 (en) 2000-12-31
JPH11501676A (ja) 1999-02-09

Similar Documents

Publication Publication Date Title
MX9805181A (es) Derivados de lactona a partir de derivados de 17.beta- carboxi, carbotio y amida androstano.
BG100946A (en) New amino acid derivatives, method for their preparation and pharmaceutical compositions containing them
ATE208772T1 (de) Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
DE69425671D1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
ATE219499T1 (de) Lipopeptid-derivate, verfahren zu ihrer herstellung und ihre verwendung
ATE220681T1 (de) Wasserlösliche camptothecin-derivate, verfahren zu deren herstellung und deren verwendung als antitumor-mittel
ATE145649T1 (de) Kardioaktive 17-aryl und 17-heterozyklyl-14 beta- 5alpha-androstane, androstene und androstadiene, ein verfahren zu ihrer herstellung und pharmazeutische präperate davon
DE59409880D1 (de) Methylphosphonsäureester, verfahren zu deren herstellung und deren verwendung
ATE264107T1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
DE69838146D1 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
DE69523622T2 (de) Diastereomerenreine 3-oxo und 3-thioxo-4-aza-androstanderivate und ihre verwendung als antiandrogene
ATE270665T1 (de) Diphenyl-substituierte 5-ring-heterocyclen, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
ATE154031T1 (de) 8-en-19, 11 beta-überbrückte steroide, deren herstellung und diese enthaltende pharmazeutische präparate
DE69609201T2 (de) 21-[2-oxo-tetrahydrofuran]-thio pregnan derivative, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon
ATE195529T1 (de) 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio- androstane derivate (17beta-(gamma-buttersäure- lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung
DE59607683D1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE59307133D1 (de) Gestagen wirksame 19,11-überbrückte 4-estrene
DE59507531D1 (de) Cyclohexanon-derivate, verfahren zu deren herstellung und zwischenprodukte des verfahrens
AP1579A (en) Novel 17-Halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same.
ATE223430T1 (de) 11.beta.-substituierte steroide, verfahren zu ihrer herstellung sowie zwischenprodukte davon, ihre verwendung als medikamente und pharmazeutische zusammensetzungen davon
DE69215511T2 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
ATE141593T1 (de) Leukotrien-b 4?-derivative, verfahren zu ihrer herstellung und arzneimittel
DE69500670T2 (de) Acetaldehyd-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee